BDO Wealth Advisors’s Nymox Pharmaceutical Corp NYMX Stock Holding History

BDO Wealth Advisors’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$893	Hold	4,700	–	–	﹤0.01%	906
2023 Q1	$1.6K	Hold	4,700	–	–	﹤0.01%	922
2022 Q4	$1.52K	Hold	4,700	–	–	﹤0.01%	882
2022 Q3	$2K	Hold	4,700	–	–	﹤0.01%	950
2022 Q2	$2K	Buy	+4,700	New	+$4.32K	﹤0.01%	933
2021 Q3	–	Sell	-4,700	Closed	-$7K	–	1149
2021 Q2	$7K	Buy	+4,700	New	+$8.71K	﹤0.01%	827
2020 Q3	–	Sell	-4,700	Closed	-$17K	–	971
2020 Q2	$17K	Hold	4,700	–	–	﹤0.01%	448
2020 Q1	$11K	Buy	+4,700	New	+$13.2K	﹤0.01%	538

Other funds holding NYMX

Corrigan Financial Middletown, Rhode Island $485M AUM 4.29% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BDO Wealth Advisors's NYMX Position: Q2 2023 in Review

BDO Wealth Advisors held its Nymox Pharmaceutical Corp (NYMX) position steady in Q2 2023 at 4,700 shares worth $893. The position accounts for ﹤0.01% of the portfolio, ranked #906.

BDO Wealth Advisors first reported a position in NYMX in Q1 2020 and has held it in 8 quarters since. The position peaked at $17K in Q2 2020. 36 funds tracked by Wall St. Rank hold NYMX as of Q2 2023.

BDO Wealth Advisors held 4,700 shares of Nymox Pharmaceutical Corp worth $893 as of Q2 2023.
BDO Wealth Advisors left its Nymox Pharmaceutical Corp share count unchanged in Q2 2023.
Nymox Pharmaceutical Corp made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #906 holding.
BDO Wealth Advisors first reported a position in Nymox Pharmaceutical Corp in Q1 2020 and has held it in 8 quarters since.
BDO Wealth Advisors's Nymox Pharmaceutical Corp position peaked at $17K in Q2 2020.
36 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.